Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07460726) titled 'PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer' on Feb. 25.

Study Type: Observational [Patient Registry]

Primary Sponsor: CancerCare Manitoba

Condition: Prostate Cancer (Adenocarcinoma) Erectile Abnormalities Sexual Dysfunction Male

Intervention: Combination Product: SBRT combined with ADT

Recruitment Status: Not recruiting

Date of First Enrollment: March 16, 2026

Target Sample Size: 130

Countries of Recruitment: Canada

To know more, visit https://clinicaltrials.gov/st...